Comparison between germline and somatic loss-of-function <i>RNF43</i> mutations reveals different genotype-phenotype associations and provides insights into the genetic mechanisms of colorectal tumourigenesis

<i>RNF43</i> is a CRC predisposition gene, but risks are moderate, the reported polyposis phenotype is often absent and molecular phenocopies can occur. N-terminal germline <i>RNF43</i> variants confer higher risk, although weak effects of C-terminal variants cannot be excluded. Genetic testing and patient management should incorporate these factors.

Authors

Institutions

Publication Details

Journal
Gut
Published
2025-12-24
DOI
https://doi.org/10.1136/gutjnl-2025-337030
Primary Topic
Genetic factors in colorectal cancer
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparison between germline and somatic loss-of-function RNF43 mutations reveals different genotype-phenotype associations and provides insights into the genetic mechanisms of colorectal tumourigenesis

Sulochana Omwenga, Sujata Biswas, Jeremy P. Cheadle, S J Leedham et al.
Gut
Genetic factors in colorectal cancer
article

Comparison between germline and somatic loss-of-function RNF43 mutations reveals different genotype-phenotype associations and provides insights into the genetic mechanisms of colorectal tumourigenesis

Sulochana Omwenga, Sujata Biswas, Jeremy P. Cheadle, S J Leedham, Juan Fernández‐Tajes, S. Thorn, Dmitri Mouradov, Luke Freeman-Mills, Sara Galavotti, Silvia Salatino, Helen Curley, Connor E. Woolley, James E. East, Nathalie Feeley, M. Sieber Oliver, Laura Chegwidden, Maughan Ts, Edward Arbe-Barnes, Roland Arnold, Claire Palles, Anshita Goel, Ian Tomlinson, Lai Mun Wang
article en

Abstract

<i>RNF43</i> is a CRC predisposition gene, but risks are moderate, the reported polyposis phenotype is often absent and molecular phenocopies can occur. N-terminal germline <i>RNF43</i> variants confer higher risk, although weak effects of C-terminal variants cannot be excluded. Genetic testing and patient management should incorporate these factors.

Gut
Centre for Human Genetics (GB), The University of Melbourne (AU), University of Basel (CH), Walter and Eliza Hall Institute of Medical Research (AU), Changi General Hospital (SG), University Hospital of Basel (CH), Edinburgh Cancer Research (GB), National Institute for Health and Care Research (GB), University of Oxford (GB), Oxford BioMedica (United Kingdom) (GB), NIHR Birmingham Biomedical Research Centre (GB), Cardiff University (GB), University of Birmingham (GB)
Wellcome Trust, Bowel Cancer UK, Cancer Research UK, National Institute for Health and Care Research, Department of Health and Social Care, University of Birmingham, Medical Research Council, NIHR Oxford Biomedical Research Centre, Birmingham Biomedical Research Centre
Openalex Percentile: Top 30%
Genetic factors in colorectal cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.